| 000 | 01184 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515144724.0 | ||
| 264 | 0 | _c20081113 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1523-6838 | ||
| 024 | 7 |
_a10.1053/j.ajkd.2008.06.034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBleyer, Anthony J | |
| 245 | 0 | 0 |
_aHyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cNov 2008 |
||
| 300 |
_a1024; author reply 1025 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAcetates _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aChelating Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperphosphatemia _xprevention & control |
| 650 | 0 | 4 |
_aPolyamines _xtherapeutic use |
| 650 | 0 | 4 | _aSevelamer |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 52 _gno. 5 _gp. 1024; author reply 1025 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ajkd.2008.06.034 _zAvailable from publisher's website |
| 999 |
_c18433072 _d18433072 |
||